14-day Premium Trial Subscription Try For FreeTry Free
FRA:HM0
Delisted

Houghton Mifflin Harcourt Company Stock Forecast

19.20€
+0 (+0%)
At Close: Aug 17, 2022
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Houghton Mifflin Harcourt Company Stock and on which exchange is it traded?
The symbol for Houghton Mifflin Harcourt Company is HM0.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Houghton Mifflin Harcourt Company Stock?
Houghton Mifflin Harcourt Company holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Houghton Mifflin Harcourt Company Stock?
Houghton Mifflin Harcourt Company Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Houghton Mifflin Harcourt Company Stock.

What's the current price of Houghton Mifflin Harcourt Company Stock?
As of the end of day on the Aug 17, 2022, the price of an Houghton Mifflin Harcourt Company (HM0.F) share was 19.20€.

What is the 52-week high and low for Houghton Mifflin Harcourt Company Stock?
The 52-week high for Houghton Mifflin Harcourt Company Stock is 19.20€ and the 52-week low is 11.00€.
Click to get the best stock tips daily for free!

About Houghton Mifflin Harcourt Company

Houghton Mifflin Harcourt Company Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... HM0.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT